商品名或批准名。第二点。观点。临床药理学家。
Trade names or approved names. Point II. Points of view. The clinical pharmacologist.
作者信息
Turner P
出版信息
Postgrad Med J. 1974 Feb;50(580):93-5. doi: 10.1136/pgmj.50.580.93.
Abstract
Differences in formulation are of greater clinical importance in the case of sparingly soluble drugs, those with small therapeutic doses, in replacement therapy and in the control of serious clinical conditions with compounds having a low therapeutic index: this subject should receive specific attention in medical teaching and in clinical trials.
摘要
对于难溶性药物、治疗剂量小的药物、替代疗法中的药物以及用治疗指数低的化合物控制严重临床病症时，制剂差异具有更大的临床重要性：在医学教学和临床试验中应特别关注这一主题。
相似文献
1
Trade names or approved names. Point II. Points of view. The clinical pharmacologist.商品名或批准名。第二点。观点。临床药理学家。
Postgrad Med J. 1974 Feb;50(580):93-5. doi: 10.1136/pgmj.50.580.93.
2
Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation.商品名或批准名。第四部分。解决方案。处方开具与制剂监管。
Postgrad Med J. 1974 Feb;50(580):125-9. doi: 10.1136/pgmj.50.580.125.
3
Trade names or approved names. Part II. Points of view. Europe.商品名或批准名。第二部分。观点。欧洲。
Postgrad Med J. 1974 Feb;50(580):73-6. doi: 10.1136/pgmj.50.580.73.
4
Trade names or approved names. Part III. Special cases. Clinical trials.商品名或批准名。第三部分。特殊情况。临床试验。
Postgrad Med J. 1974 Feb;50(580):114-20. doi: 10.1136/pgmj.50.580.114.
5
Trade names or approved names. Part III. Special cases. The digoxin affair.商品名或批准名。第三部分。特殊情况。地高辛事件。
Postgrad Med J. 1974 Feb;50(580):98-102. doi: 10.1136/pgmj.50.580.98.
6
Trade names or approved names. Part II. Points of view. The pharmaceutical company.商品名或批准名。第二部分。观点。制药公司。
Postgrad Med J. 1974 Feb;50(580):85-7. doi: 10.1136/pgmj.50.580.85.
7
Bioavailability studies and the clinical pharmacologist: correlation of drug distribution with clinical effects.生物利用度研究与临床药理学家：药物分布与临床效应的相关性
Int J Clin Pharmacol Biopharm. 1975 Jun;11(4):349-54.
8
Trade names or approved names. Part III. Special cases. Antibiotics.商品名或批准名。第三部分。特殊情况。抗生素。
Postgrad Med J. 1974 Feb;50(580):96-7. doi: 10.1136/pgmj.50.580.96.
9
Are all warfarin preparations Alike? A comprehensive overview of current data, emerging opinions, and perspectives.
J Thromb Thrombolysis. 2000 Feb;9(2):139-44. doi: 10.1023/a:1018768913156.
10
Editorial: Bio-availability and clinical efficacy of a drug.社论：药物的生物利用度与临床疗效
J Indian Med Assoc. 1973 Jul 16;61(2):94-5.
本文引用的文献
1
Outbreak of anticonvulsant intoxication in an Australian city.澳大利亚一座城市发生抗惊厥药物中毒事件。
Br Med J. 1970 Oct 31;4(5730):271-3. doi: 10.1136/bmj.4.5730.271.
2
Formulation and therapeutic efficacy of drugs used in clinical trials.用于临床试验的药物的配方与治疗效果。
Lancet. 1969 Jul 12;2(7611):98-9. doi: 10.1016/s0140-6736(69)92406-4.
3
Rate of dissolution of digoxin tablets as a predictor of absorption.
Lancet. 1973 Jun 30;1(7818):1473-5. doi: 10.1016/s0140-6736(73)91811-4.
Zotero 插件